Abstract
The early stages of drug discovery heavily rely on high-throughput screening (HTS) of compound libraries to identify effective lead compounds. Biochemical and cell-based assays have been commonly performed with the assistance of robotic liquid dispensing systems to rapidly test and identify the potential efficacy and toxicity of drug candidates [1, 2]. In an effort to save costs and reduce expensive resources such as primary human cells and reagents, pharmaceutical industries have focused on miniaturizing HTS assays by using higher density well plates including 384- and 1536-well plates, leading to a reduction in reagent volumes and an increase the speed of the liquid dispensing [1, 3].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
